It is an recombinant Campylobacter jejuni β1,3-galactosyltransferase (CgtB) produced in E. coli. This product can be used to study the mode of action of the enzyme and its potential inhibitors, and can also be used as a glycoengineering tool to modify glycoproteins in vitro.
Unit Definition
One unit will catalyze the formation of 1 μmol Galβ(1-3)Gal from Gal and UDP-Gal per min at 37°C.
Source
Campylobacter jejuni
Form
Lyophilized powder
Purity
>95%, determined by SDS-PAGE.
Applications
Study the mode of action of the enzyme and its potential inhibitors and as a glycoengineering tool to modify glycoproteins in vitro.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
